BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8921370)

  • 1. Genomic sequence, organization, and chromosomal localization of human JAK3.
    Riedy MC; Dutra AS; Blake TB; Modi W; Lal BK; Davis J; Bosse A; O'Shea JJ; Johnston JA
    Genomics; 1996 Oct; 37(1):57-61. PubMed ID: 8921370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural organization and chromosomal mapping of JAK3 locus.
    Kumar A; Toscani A; Rane S; Reddy EP
    Oncogene; 1996 Nov; 13(9):2009-14. PubMed ID: 8934548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
    Gurniak CB; Thomis DC; Berg LJ
    DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised exon-intron structure of human JAK3 locus.
    Brooimans RA; van der Slot AJ; van den Berg AJ; Zegers BJ
    Eur J Hum Genet; 1999; 7(7):837-40. PubMed ID: 10573019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
    Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
    Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK3: expression and mapping to chromosome 19p12-13.1.
    Safford MG; Levenstein M; Tsifrina E; Amin S; Hawkins AL; Griffin CA; Civin CI; Small D
    Exp Hematol; 1997 May; 25(5):374-86. PubMed ID: 9168059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
    Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD
    Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.
    Chen M; Cheng A; Candotti F; Zhou YJ; Hymel A; Fasth A; Notarangelo LD; O'Shea JJ
    Mol Cell Biol; 2000 Feb; 20(3):947-56. PubMed ID: 10629052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia.
    Cools J; Peeters P; Voet T; Aventin A; Mecucci C; Grandchamp B; Marynen P
    Cytogenet Cell Genet; 1999; 85(3-4):260-6. PubMed ID: 10449913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, characterization, and genomic structure of carp JAK1 kinase gene.
    Chang MS; Chang GD; Leu JH; Huang FL; Chou CK; Huang CJ; Lo TB
    DNA Cell Biol; 1996 Oct; 15(10):827-44. PubMed ID: 8892755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia.
    Wood CM; Goodman PA; Uckun FM
    Leuk Lymphoma; 2002 Dec; 43(12):2355-62. PubMed ID: 12613524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism.
    Schumacher RF; Mella P; Badolato R; Fiorini M; Savoldi G; Giliani S; Villa A; Candotti F; Tampalini A; O'Shea JJ; Notarangelo LD
    Hum Genet; 2000 Jan; 106(1):73-9. PubMed ID: 10982185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes.
    Leu JH; Yan SJ; Lee TF; Chou CM; Chen ST; Hwang PP; Chou CK; Huang CJ
    DNA Cell Biol; 2000 Jul; 19(7):431-46. PubMed ID: 10945233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
    Rane SG; Reddy EP
    Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
    Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
    Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary analysis for functional divergence of Jak protein kinase domains and tissue-specific genes.
    Gu J; Wang Y; Gu X
    J Mol Evol; 2002 Jun; 54(6):725-33. PubMed ID: 12029354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain.
    Raivola J; Hammarén HM; Virtanen AT; Bulleeraz V; Ward AC; Silvennoinen O
    Front Oncol; 2018; 8():560. PubMed ID: 30560087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.
    Takahashi T; Shirasawa T
    FEBS Lett; 1994 Apr; 342(2):124-8. PubMed ID: 8143863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jak3 and the pathogenesis of severe combined immunodeficiency.
    O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
    Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.